학술논문

Efficacy of Granulocyte and Monocyte Adsorption Apheresis for Pustular Psoriasis
Document Type
Report
Author abstract
Source
Therapeutic Apheresis and Dialysis. Feb, 2008, Vol. 12 Issue 1, p13, 6 p.
Subject
Psoriasis
Adsorption
Retinoids
Language
English
ISSN
1744-9979
Abstract
To purchase or authenticate to the full-text of this article, please visit this link: http://dx.doi.org/10.1111/j.1744-9987.2007.00536.x Byline: Mariko Seishima (1), Yoko Mizutani (1), Yoshinao Shibuya (1), Chikako Nagasawa (1), Takahiko Aoki (2) Keywords: Acrodermatitis continua; Generalized pustular psoriasis; Granulocyte and monocyte adsorption apheresis; Pustular psoriasis; Treatment Abstract: Abstract: Granulocyte and monocyte adsorption apheresis (GCAP) has recently shown remarkable effects on ulcerative colitis, which is characterized by inflammation and neutrophil infiltration. Pustular psoriasis often shows histological findings of neutrophilic pustules in the epidermis, and in Japan is usually treated with etretinate or immunosuppressive agents. However, there are some resistant cases to these therapies. We performed GCAP on one patient with generalized pustular psoriasis (patient 1) and on one patient with acrodermatitis continua, a subtype of pustular psoriasis limited to acral lesions (patient 2). Patient 1, a 44-year-old woman suffering from alcoholic liver cirrhosis and osteoporosis as a result of the liver cirrhosis, received two GCAP sessions because cyclosporine was ineffective. Patient 2, a 66-year-old man with hypertension who had suffered from a brain infarction 4 years before, had five GCAP sessions because etretinate was ineffective. GCAP remarkably improved the skin lesions in both patients. No adverse effects were observed either during or after treatment. From these findings, GCAP could be an effective therapy for refractory cases of pustular psoriasis. Author Affiliation: Departments of(1)Dermatology and (2)Nephrology, Ogaki Municipal Hospital, Ogaki City, Japan Article History: Received December 2006; revised March 2007. Article note: Dr Mariko Seishima, Department of Dermatology, Ogaki Municipal Hospital, Minaminokawa-cho 4-86, Ogaki City 503-8502, Japan. Email: marikoseishima@yahoo.co.jp